Should We Complete National Registration First or Find a Local Distributor First?

Should We Complete National Registration First or Find a Local Distributor First?

Answer: National registration and local distributor selection should be considered in parallel, but the registration pathway and certificate control must be designed first. Registration determines whether the product can be legally marketed, while the local distributor determines whether the product can enter channels and reach end customers. If a distributor is locked in before registration is properly handled, risks may arise in certificate ownership, agent authority, channel replacement, and documentation transfer. For countries with high regulatory barriers or long timelines, it is advisable to first confirm registration feasibility, local agent arrangements, and documentation gaps, and only then define the boundaries of the distribution cooperation.

This FAQ was prepared by the AIMEILI Regulatory Editorial Team based on public regulatory materials, registration practice, and medical device international registration knowledge.

Published: 2026-07-08 09:00

Updated: 2026-07-08 09:00

This FAQ addresses priority decisions that companies need to make in actual projects regarding international medical device registration, documentation preparation, compliance pathways, and post-market maintenance.

Content Structure

• Key Summary
• Decision Logic
• Documentation Priorities
• Common Pitfalls
• AIMEILI Perspective
• Further Reading
• Applicability Boundaries

Key Summary

National registration and local distributor selection should be considered in parallel, but the registration pathway and certificate control must be designed first. Registration determines whether the product can be legally marketed, while the local distributor determines whether the product can enter channels and reach end customers. If a distributor is bound first and registration is handled later, risks may arise in certificate ownership, agent authority, channel replacement, and documentation transfer. For countries with high regulatory barriers or long timelines, it is advisable to first confirm registration feasibility, local agent arrangements, and documentation gaps, and only then define the boundaries of the distribution cooperation.

Decision Logic

Companies should first assess the target market, registration pathway, commercial launch plan, and current documentation status in the same planning framework. Without an initial pathway assessment, subsequent work may be repeatedly reworked in areas such as local agent arrangements, labeling, testing, clinical evidence, or certificate maintenance.

Documentation Priorities

Cost and timeline assessments should be broken down into official fees, third-party testing or certification fees, local agent fees, translation and notarization fees, documentation remediation costs, and ongoing maintenance costs. Looking only at application fees or official review timelines usually does not reflect the true project investment.

Common Pitfalls

A common pitfall is treating the local agent as an ordinary business contact and overlooking its responsibilities for receiving regulatory notifications, maintaining certificates, supporting adverse event handling, and transferring documentation. If the agent arrangement is unclear, it may later affect channel replacement and market control.

AIMEILI Perspective

AIMEILI recommends that companies evaluate this question at the project initiation stage as part of a unified assessment, rather than handling it on an ad hoc basis just before submission. A more reliable approach is to first complete product classification, documentation gap assessment, target-country prioritization, local responsible party arrangements, and post-market maintenance planning, and then form an executable registration plan.

Further Reading

• Previous: Can the same product reuse registration pathways across multiple countries?
• Next: Why does product classification affect registration timelines and costs?

Recommended Reading

• How do UDI and product classification codes affect overseas registration?
• How should medical device companies choose their first batch of target countries for going global?
• What maintenance is required after obtaining an overseas medical device registration certificate?
• How is a technical file gap assessment conducted for overseas medical device registration?
• What are the technical file requirements for medical devices under EU MDR?
• What procedures are required for exporting Chinese medical devices to Indonesia?
• Return to FAQ Center
• News
• Contact AIMEILI

Content Review and Applicability Boundaries

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI Medical Device International Registration Project Team

Source principle: Priority is given to official regulatory agencies, international organizations, standards organizations, and public regulatory materials; industry media and project experience are used only as auxiliary references for judgment.

Applicability boundaries: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements of the target country regulatory authority, testing conclusions, or legal advice.